US Stocks
/
Revelation Biosciences, Inc. Share Price

Revelation Biosciences, Inc. Share Price

NASDAQ: REVB | Micro Cap
$1.06
+$0.06 (6.37%) Last updated on 29 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Revelation Biosciences, Inc. Stock Performance

Open
$1.05
Prev. Close
$1.00
Circuit Range
N/A
Day Range
$1.03 - $1.06
Year Range
$0.47 - $2.90
Volume
679
Average Traded
$1.04

Revelation Biosciences, Inc. Share Price Today

As of 29 August 2026, Revelation Biosciences, Inc.'s share price is $1.06. The stock opened at $1.05, compared to its previous close of $1.00. During today's trading session, Revelation Biosciences, Inc.'s share price traded between $1.03 and $1.06, with an average price of $1.05. Over the past 52 weeks, the stock has recorded a high of $2.90 and a low of $0.47. In terms of performance, Revelation Biosciences, Inc.'s share price has declined by 19.70% over the last six months and is down 61.17% on a year-on-year basis.

Revelation Biosciences, Inc. Share Price Chart

$1.03$1.06
L
Show Current Price
H

Revelation Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$658032.10
PE Ratio (TTM)
-0.04
Dividend Yield
N/A
EPS (TTM)
$-23.95
Revenue (TTM)
N/A
Return On Equity (TTM)
-100.59%
Profit Margin
N/A
Debt to Equity
0.23
Quarterly Earnings Growth YoY
14.92%

Revelation Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$2.68M-$8.39M-$2.24M-$2.05M-$2.44M-$1.91M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-212.89%73.28%8.50%-19.18%21.98%

Revelation Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
RevenueN/AN/AN/AN/A
Net Profit-$10.83M-$120254.00-$15.04M-$8.91M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A98.89%-12405.64%40.73%

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Revelation Biosciences, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.01
$1.03
+8.42%
Jul 2026
$1.04
$0.95
-7.77%
Jun 2026
$1.06
$1.03
-6.36%
May 2026
$1.05
$1.10
-4.35%
Apr 2026
$1.21
$1.15
-6.50%
Mar 2026
$1.30
$1.23
-6.82%
Feb 2026
$1.89
$1.32
-34.16%
Jan 2026
$0.81
$2.00
+152.20%
Dec 2025
$0.98
$0.80
-17.70%
Nov 2025
$1.19
$0.97
-22.10%
Oct 2025
$1.44
$1.24
-11.43%
Sep 2025
$2.63
$1.40
-48.72%

REVB Share Price FAQs

What is Revelation Biosciences, Inc. share price today?

chevron-up
Revelation Biosciences, Inc. share price today is $1.06 as on August 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Revelation Biosciences, Inc. stock?

chevron-up
The 52 week high of Revelation Biosciences, Inc. stock is $2.90, while the 52 week low is $0.47 as of 29 Aug '26.

What is REVB's market capitalisation today?

chevron-up
REVB market capitalisation is $658032.10 as of August 29, 2026, at 10:21 pm IST.

What is REVB's net income for the last quarter?

chevron-up
REVB's net income for the last quarter is -0.00B USD.

What is the 5 year returns of REVB?

chevron-up
The 5 year returns of REVB is -100.00% as on 29 Aug '26.

What is the high & low stock price of REVB today?

chevron-up
REVB stock price hit a high of $1.06 and low of $1.03 as of 29 Aug '26.

Can I buy REVB shares in India?

chevron-up
Yes. You can buy REVB in India by opening an international trading account.